This pharmaceutical company performs research to develop and commercialise therapeutic treatments for a variety of rare diseases, including rare epileptic syndromes and mitochondrial disorders.
This pharmaceutical company performs research to develop and commercialise therapeutic treatments for a variety of rare diseases, including rare epileptic syndromes and mitochondrial disorders.